Nguyen et al. pointed out that CAF-derived LOXL2 produced a highly aligned ECM by autocrine and paracrine signaling in tumor microenvironment in prostate cancer, thereby promoting the migration of CAF and neighbored prostate tumor cells52. This evidence concerns the gene LOXL2 and prostate cancer.